Company intelligence / Profile preview

Innopsys

Carbonne, Occitanie (Midi-Pyrénées region), Franceinnopsys.com ↗

Ownership: Private
Employees: ~29
Development stage: Commercial

Overview

Innopsys develops and commercializes advanced microarray scanners and associated software for biotechnological and medical research laboratories. Their products are used globally in over 50 countries for applications including genomics, proteomics, diagnostics, single-cell analysis, biosensors for IVD markets, environmental monitoring, and life sciences. The company is recognized as a leader in the microarray scanning market with ongoing innovation through significant R&D investment.

Modalities: Microarray scannersFluorescence confocal scanners
Industry: Molecular Diagnostics

Partnerships

LAAS-CNRS joint laboratory "Biosoft" for collaborative R&D

Beyond the preview

Go deeper on Innopsys.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innopsys.

Explore the full profile